Praxis Precision Medicines, Inc. (PRAX) Q1 2026 Earnings
PRAX·Reported May 7, 2026·Before market open
Diluted EPS came in at $-3.20 (+2.7% YoY), beat the $-3.58 consensus by $0.38.
Diluted EPS
$-3.20beat by $0.38
Consensus: $-3.58
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Praxis Precision Medicines, Inc.'s Q1 2026 earnings report.
Praxis Precision Medicines, Inc. (PRAX) reported Q1 2026 earnings on May 7, 2026 before market open.
Praxis Precision Medicines, Inc. reported diluted EPS of $-3.20 for Q1 2026.
EPS beat the consensus estimate of $-3.58 by $0.38.
Compared to the same quarter a year prior, diluted EPS grew 2.7% from $-3.29.
You can read the 10-Q periodic report (0001689548-26-000047) directly on SEC EDGAR. The filing index links above go to sec.gov.